The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The "Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been ...

Investing in dividend-paying stocks has long been a strategy for investors seeking regular income and potential for capital ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

The new American College of Cardiology expert consensus includes a four-part staging system with a segment for “asymptomatic” ...

Phillip Frost, the CEO and Chairman of OPKO Health, Inc. (NASDAQ:OPK), has recently increased his stake in the company. According to a Form 4 filing with the Securities and Exchange Commission, Frost ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...